With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.

Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging / Picano E.; Ciampi Q.; Cortigiani L.; Arruda-Olson A.M.; Borguezan-Daros C.; Pretto J.L.C.E.S.; Cocchia R.; Bossone E.; Merli E.; Kane G.C.; Varga A.; Agoston G.; Scali M.C.; Morrone D.; Simova I.; Samardjieva M.; Boshchenko A.; Ryabova T.; Vrublevsky A.; Palinkas A.; Palinkas E.D.; Sepp R.; Torres M.A.R.; Villarraga H.R.; Preradovic T.K.; Citro R.; Amor M.; Mosto H.; Salame M.; Leeson P.; Mangia C.; Gaibazzi N.; Tuttolomondo D.; Prota C.; Peteiro J.; Van De Heyning C.M.; D'Andrea A.; Rigo F.; Nikolic A.; Ostojic M.; Lowenstein J.; Arbucci R.; Lowenstein Haber D.M.; Merlo P.M.; Wierzbowska-Drabik K.; Kasprzak J.D.; Haberka M.; Camarozano A.C.; Ratanasit N.; Mori F.; D'Alfonso M.G.; Tassetti L.; Milazzo A.; Olivotto I.; Marchi A.; Rodriguez-Zanella H.; Zagatina A.; Padang R.; Dekleva M.; Djordievic-Dikic A.; Boskovic N.; Tesic M.; Giga V.; Beleslin B.; Di Salvo G.; Lorenzoni V.; Cameli M.; Mandoli G.E.; Bombardini T.; Caso P.; Celutkiene J.; Barbieri A.; Benfari G.; Bartolacelli Y.; Malagoli A.; Bursi F.; Mantovani F.; Villari B.; Russo A.; De Nes M.; Carpeggiani C.; Monte I.; Re F.; Cotrim C.; Bilardo G.; Saad A.K.; Karuzas A.; Matuliaskas D.; Colonna P.; Antonini-Canterin F.; Pepi M.; Pellikka P.A.. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - ELETTRONICO. - 10:(2021), pp. 3641-3641. [10.3390/jcm10163641]

Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging

Mori F.;D'Alfonso M. G.;Tassetti L.;Milazzo A.;Olivotto I.;Marchi A.;Mantovani F.;
2021

Abstract

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
2021
10
3641
3641
Picano E.; Ciampi Q.; Cortigiani L.; Arruda-Olson A.M.; Borguezan-Daros C.; Pretto J.L.C.E.S.; Cocchia R.; Bossone E.; Merli E.; Kane G.C.; Varga A.; Agoston G.; Scali M.C.; Morrone D.; Simova I.; Samardjieva M.; Boshchenko A.; Ryabova T.; Vrublevsky A.; Palinkas A.; Palinkas E.D.; Sepp R.; Torres M.A.R.; Villarraga H.R.; Preradovic T.K.; Citro R.; Amor M.; Mosto H.; Salame M.; Leeson P.; Mangia C.; Gaibazzi N.; Tuttolomondo D.; Prota C.; Peteiro J.; Van De Heyning C.M.; D'Andrea A.; Rigo F.; Nikolic A.; Ostojic M.; Lowenstein J.; Arbucci R.; Lowenstein Haber D.M.; Merlo P.M.; Wierzbowska-Drabik K.; Kasprzak J.D.; Haberka M.; Camarozano A.C.; Ratanasit N.; Mori F.; D'Alfonso M.G.; Tassetti L.; Milazzo A.; Olivotto I.; Marchi A.; Rodriguez-Zanella H.; Zagatina A.; Padang R.; Dekleva M.; Djordievic-Dikic A.; Boskovic N.; Tesic M.; Giga V.; Beleslin B.; Di Salvo G.; Lorenzoni V.; Cameli M.; Mandoli G.E.; Bombardini T.; Caso P.; Celutkiene J.; Barbieri A.; Benfari G.; Bartolacelli Y.; Malagoli A.; Bursi F.; Mantovani F.; Villari B.; Russo A.; De Nes M.; Carpeggiani C.; Monte I.; Re F.; Cotrim C.; Bilardo G.; Saad A.K.; Karuzas A.; Matuliaskas D.; Colonna P.; Antonini-Canterin F.; Pepi M.; Pellikka P.A.
File in questo prodotto:
File Dimensione Formato  
jcm-10-03641-v2.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 786.5 kB
Formato Adobe PDF
786.5 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1261232
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 16
social impact